Evidence map›Paper›PMID 39328436›Full record

ArticleVeterinary world2024

A novel recombinant

Anara Ryskeldina, Aleksandr Korobeinikov, Nailya Tursunbay, Maxat Berdikulov, Alexandr Shevtsov, Christian Bauer, Yersyn Mukhanbetkaliyev, Marat Kuibagarov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary world, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Theileria annulata diagnostics: past, present and future.Tropical animal health and production · 2026
    Review
  2. Experimental induction ofOpen veterinary journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anara RyskeldinaNational Center for Biotechnology, 01000, Astana, Kazakhstan.
Aleksandr KorobeinikovNational Center for Biotechnology, 01000, Astana, Kazakhstan.
Nailya TursunbayNational Center for Biotechnology, 01000, Astana, Kazakhstan.
Maxat BerdikulovNational Veterinary Reference Center, 010000, Astana, Kazakhstan.
Alexandr ShevtsovNational Center for Biotechnology, 01000, Astana, Kazakhstan.
Christian BauerS. Seifullin Kazakh Agro Technical Research University, 010011, Astana, Kazakhstan.
Yersyn MukhanbetkaliyevS. Seifullin Kazakh Agro Technical Research University, 010011, Astana, Kazakhstan.
Marat KuibagarovNational Center for Biotechnology, 01000, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Materials and Methods: Recombinant TaSP was obtained by cloning a polymorphic region of the TaSP gene, expressing it in Results: The obtained recombinant protein had a molecular weight of 32 kDa, and mass spectrometry analysis of the purified protein identified it as a fragment of the surface protein of Conclusion: Initial results using recombinant TaSP as an antigen in indirect ELISA are promising and support the widespread use of this assay for routine diagnosis and

Indexed as

cattleindirect enzyme-linked immunosorbent assayKazakhstanrecombinant T. annulata surface proteinTheileria annulata

Identifiers

PMID39328436
PMCPMC11422651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.